Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference9 articles.
1. Unger T, Borghi C, Charchar F, et al. 2020 International Society of Hypertension global hypertension practice guidelines. J Hypertens. 2020;38(6):982–1004.
2. Geldsetzer P, Manne-Goehler J, Marcus ME, et al. The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults. Lancet. 2019;394(10199):652–62.
3. NCD Risk Factor Collaboration (NCD-RisC). Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys. Lancet. 2019;394(10199):639–51.
4. European Commission. A Guideline on Summary of Product Characteristics October 2005. http://www.kardio.hr/wp-content/uploads/2012/12/spcguidrev1-oct2005_en.pdf. Accessed 28 May 2021.
5. Federal Register. Tuesday, January 24, 2006. Requirements on Content and Format of Labeling for Human Prescription Drug and Biological Products. https://www.govinfo.gov/content/pkg/FR-2006-01-24/pdf/06-545.pdf. Accessed 28 May 2021.